Assessing evidence from clinical trials in chronic hepatitis C.

about

Controlled release recombinant human interferon-α2b for treating patients with chronic hepatitis C genotype 1: a phase 2a clinical trial.

P2860

Q42996026-506BD772-12E4-4687-A02E-B50246C752FF

P2860

Assessing evidence from clinical trials in chronic hepatitis C.

Item

http://www.wikidata.org/entity/Q36455982

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Assessing evidence from clinical trials in chronic hepatitis C.

@ast

Assessing evidence from clinical trials in chronic hepatitis C.

@en

type

Item

label

Assessing evidence from clinical trials in chronic hepatitis C.

@ast

Assessing evidence from clinical trials in chronic hepatitis C.

@en

prefLabel

Assessing evidence from clinical trials in chronic hepatitis C.

@ast

Assessing evidence from clinical trials in chronic hepatitis C.

@en

P1476

Assessing evidence from clinical trials in chronic hepatitis C.

@en

P2093

Bacon BR

http://www.w3.org/2001/XMLSchema#string

P2860

Costs of hepatitis C

Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

Natural history of hepatitis C: its impact on clinical management.

Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys.

Targeting NS5B RNA-dependent RNA polymerase for anti-HCV chemotherapy.

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1111/J.1365-2893.2006.00755.X

http://www.w3.org/2001/XMLSchema#string

P478

13 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16630041

http://www.w3.org/2001/XMLSchema#string

Assessing evidence from clinical trials in chronic hepatitis C.

about

P2860

P2860

Assessing evidence from clinical trials in chronic hepatitis C.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698